Open access · CC-BY
via OpenAlex
Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease
Richard Parker, Mark S. Schmidt, Owen Cain, Bridget Gunson, Charles Brenner
Hepatology Communications · 2020 · ▲ 27 citations
Abstract
Nicotinamide adenine dinucleotide (NAD + ) and related coenzymes play critical roles in liver function. Although hepatic alcohol metabolism depresses NAD + , current understanding of the NAD + metabolome in alcohol‐related liver disease (ArLD) is based on animal models. We used human liver samples to quantify the NAD + metabolome in ArLD with samples obtained at the time of liver transplantation or resection at University Hospitals Birmingham National Health Service Foundation Trust. The severity of steatohepatitis in liver from patients with ArLD was assessed with standard liver function tests and histology. NAD‐targeted quantitative metabolomic analysis of liver tissue was performed by liquid chromatography–tandem mass spectrometry. Seventy‐two human liver specimens were analyzed, including 43 with ArLD. The NAD + metabolome differed significantly between different types of liver disease (two‐way analysis of variance [ANOVA], P = 0.001). ArLD liver tissue showed markedly depressed concentrations of NAD + (432 μM vs. 616 μM in normal liver) and precursor molecules nicotinic acid and nicotinamide riboside. There was a significant overall difference in the NAD + metabolome between ArLD samples with and without steatohepatitis (two‐way ANOVA, P = 0.018). After correcting for multiple comparisons, a significant difference for individual components of the metabolome was observed for the concentration of NAD + (mean, 462 μM vs. 322 μM; P < 0.01 in nonsevere vs. severe alcoholic steatohepatitis, respectively). NAD + concentration was inversely related to serum bilirubin concentration ( r 2 = −0.127; P = 0.04) and positively correlated with myeloperoxidase activity ( r 2 = 0.31; P = 0.003). The concentration of NAD + and its precursor molecules are significantly reduced in ArLD and are associated with disease activity. Conclusion : Liver samples from people with ArLD show depressed NAD + and precursor levels as well as depressed myeloperoxidase activity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/hep4.1530
- Canonical
- link ↗
- Fetched
- 2026-06-24 MST
Cite this
APA
Parker, R., Schmidt, M.S., Cain, O., Gunson, B., & Brenner, C. (2020). Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease. <em>Hepatology Communications</em>. https://doi.org/10.1002/hep4.1530
Vancouver
Parker R, Schmidt MS, Cain O, Gunson B, Brenner C. Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease. Hepatology Communications. 2020. doi:10.1002/hep4.1530.
BibTeX
@article{richard2020Nicoti,
title = {Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease},
author = {Richard Parker and Mark S. Schmidt and Owen Cain and Bridget Gunson and Charles Brenner},
journal = {Hepatology Communications},
year = {2020},
doi = {10.1002/hep4.1530},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Milton S. Hershey Medical Center 2021
Open access · US-GOV
Frailty in Liver Transplant Exercise (FLEX) Trial
University of California, San Francisco 2016
Open access · US-GOV
Exercise Intervention in Liver Transplant Patients
Redox Biology 2018
Open access · CC-BY
Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
2016
Preprint · OA
Novel NAD+ metabolomic technologies and their applications to Nicotinamide Riboside interventions
Cell Reports 2018
Open access · CC-BY
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease
Scientific Reports 2022
Open access · CC-BY